Join to View Full Profile
Ut Physicians Movement Disorders And Neurodegenerative Diseases6410 Fannin St. Ste 1010Houston, TX 77030
Phone+1 713-500-7117
Fax+1 713-500-7120
Dr. Mehanna is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Raja Mehanna is a neurologist in Houston, TX and is affiliated with Memorial Hermann - Texas Medical Center. He received his medical degree from St Joseph's University Medical School and has been in practice 15 years. He is fluent in French and Arabic and speaks conversational Spanish. He specializes in movement disorder and is also experienced in deep brain stimulation and botulinum toxin injections.
Education & Training
Cleveland Clinic FoundationFellowship, Neuromuscular Medicine (Neurology), 2012 - 2013
Baylor College of MedicineFellowship, Stereotactic & Movement Disorders, 2011 - 2012- Baylor College of MedicineResidency, Neurology, 2008 - 2011
- Baylor College of MedicineInternship, Internal Medicine, 2007 - 2008
St Joseph's University Medical SchoolClass of 2005
Certifications & Licensure
TX State Medical License 2013 - 2027
OH State Medical License 2012 - 2014
IN State Medical License 2011 - 2013
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- Dean's Award for excellence in teaching University of Texas Mc Govern medical School, 2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise EHR, Allscripts, 2014-2017
- CMS Meaningful Use Stage 1 Certification Allscripts Enterprise E HR, Allscripts, 2014-2017
Clinical Trials
- Sustained Effect of Droxidopa in Symptomatic Neurogenic Orthostatic Hypotension Start of enrollment: 2016 Feb 11
- Utilization of Target Ranges to Treat Parkinson's Disease With the PKG Start of enrollment: 2019 Oct 15
- Utilization of Target Ranges to Treat Persons With Parkinson's Disease by Objective Measurement Using the PKG Start of enrollment: 2020 Jun 01
Publications & Presentations
PubMed
- 2 citationsDiagnostic work up when suspecting early onset Parkinson disease (EOPD). Recommendations from the MDS EOPD study group.Raja Mehanna, Connie Marras, Jori Fleisher, Bart Post, Kishore Raj Kumar
Parkinsonism & Related Disorders. 2025-06-01 - 3 citationsValbenazine for the treatment of chorea associated with Huntington's disease.Jorge Patino, Erin Furr Stimming, Claudia M Testa, Raja Mehanna
Expert Opinion on Pharmacotherapy. 2025-02-01 - Rethinking Parkinson's disease genetics in the precision medicine era: why genomic diversity matters?Camilla Teixeira Pinheiro Gusmão, Giselli Scaini, Everton Ferreira de Souza, Rafael Antônio Vicente Lacerda, Matheus de Almeida Costa
Frontiers in Genetics. 2025-01-01
Journal Articles
- Comprehensive, Multi-disciplinary DBS Screening for Parkinson Patients: No Room for “Short Cuts”.Abboud H, Mehanna R, Machado A, Ahmed A, Gostkowski M, Cooper S, Itin I, Sweeney P, Pandya M, Kubu C, Floden D, Ford PJ, Fernandez HH., Movement Disorders Clinical Practice, 10/2014
- Comparing 2 deep brain stimulation leads to one in refractory tremor.Mehanna R, Machado AG, Oravivattanakul S, Genc G, Cooper SE., Cerebellum, 8/2014
- Unrecognized vitamin D3 deficiency is common in Parkinson disease: Harvard Biomarker Study.Mehanna R, Neurology, 5/6/2014
Professional Memberships
- Member
- International Parkinson's Disease and Movement Disorders SocietyMember
- Parkinson Study GroupMember
- Member
Other Languages
- French, Arabic
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
